IRIS Accounts Production v24.3.2.46 07108631 Board of Directors 1.4.23 31.3.24 31.3.24 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh071086312023-03-31071086312024-03-31071086312023-04-012024-03-31071086312022-03-31071086312022-04-012023-03-31071086312023-03-3107108631ns15:EnglandWales2023-04-012024-03-3107108631ns14:PoundSterling2023-04-012024-03-3107108631ns10:Director12023-04-012024-03-3107108631ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107108631ns10:SmallEntities2023-04-012024-03-3107108631ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3107108631ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3107108631ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3107108631ns10:FullAccounts2023-04-012024-03-3107108631ns10:Director22023-04-012024-03-3107108631ns10:RegisteredOffice2023-04-012024-03-3107108631ns5:CurrentFinancialInstruments2024-03-3107108631ns5:CurrentFinancialInstruments2023-03-3107108631ns5:ShareCapital2024-03-3107108631ns5:ShareCapital2023-03-3107108631ns5:RetainedEarningsAccumulatedLosses2024-03-3107108631ns5:RetainedEarningsAccumulatedLosses2023-03-3107108631ns5:PlantMachinery2023-04-012024-03-3107108631ns5:FurnitureFittings2023-04-012024-03-3107108631ns5:ComputerEquipment2023-04-012024-03-3107108631ns5:PlantMachinery2023-03-3107108631ns5:FurnitureFittings2023-03-3107108631ns5:ComputerEquipment2023-03-3107108631ns5:PlantMachinery2024-03-3107108631ns5:FurnitureFittings2024-03-3107108631ns5:ComputerEquipment2024-03-3107108631ns5:PlantMachinery2023-03-3107108631ns5:FurnitureFittings2023-03-3107108631ns5:ComputerEquipment2023-03-3107108631ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3107108631ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3107108631ns5:DeferredTaxation2024-03-3107108631ns5:RetainedEarningsAccumulatedLosses2023-03-3107108631ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-31
REGISTERED NUMBER: 07108631 (England and Wales)















Kardiacor Ltd

Unaudited Financial Statements for the Year Ended 31st March 2024






Kardiacor Ltd (Registered number: 07108631)






Contents of the Financial Statements
for the year ended 31st March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Kardiacor Ltd

Company Information
for the year ended 31st March 2024







DIRECTORS: Dr J P M Foran
Mrs D M Foran



REGISTERED OFFICE: 8, Blandfield Road
London
SW12 8BG



REGISTERED NUMBER: 07108631 (England and Wales)



ACCOUNTANTS: The Decimal Place
8 Blandfield Road
London
SW12 8BG



BANKERS: Barclays Bank

Kardiacor Ltd (Registered number: 07108631)

Balance Sheet
31st March 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 26,207 3

CURRENT ASSETS
Debtors 5 7,799 10,357
Cash at bank and in hand 21,855 62,924
29,654 73,281
CREDITORS
Amounts falling due within one
year

6

7,916

21,451
NET CURRENT ASSETS 21,738 51,830
TOTAL ASSETS LESS CURRENT
LIABILITIES

47,945

51,833

PROVISIONS FOR LIABILITIES 7 4,979 -
NET ASSETS 42,966 51,833

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 8 42,866 51,733
SHAREHOLDERS' FUNDS 42,966 51,833

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Kardiacor Ltd (Registered number: 07108631)

Balance Sheet - continued
31st March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19th January 2025 and were signed on its behalf by:





Dr J P M Foran - Director


Kardiacor Ltd (Registered number: 07108631)

Notes to the Financial Statements
for the year ended 31st March 2024

1. STATUTORY INFORMATION

Kardiacor Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on cost
Fixtures and fittings - 25% on cost
Computer equipment - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Kardiacor Ltd (Registered number: 07108631)

Notes to the Financial Statements - continued
for the year ended 31st March 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1st April 2023 33,422 20,568 5,554 59,544
Additions - 34,938 - 34,938
At 31st March 2024 33,422 55,506 5,554 94,482
DEPRECIATION
At 1st April 2023 33,421 20,567 5,553 59,541
Charge for year - 8,734 - 8,734
At 31st March 2024 33,421 29,301 5,553 68,275
NET BOOK VALUE
At 31st March 2024 1 26,205 1 26,207
At 31st March 2023 1 1 1 3

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE
YEAR
2024 2023
£    £   
Other debtors - 10,357
Directors' current accounts 7,799 -
7,799 10,357

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 1 -
Tax 4,811 16,145
Directors' current accounts - 2,293
Accruals and deferred income 3,104 3,013
7,916 21,451

Kardiacor Ltd (Registered number: 07108631)

Notes to the Financial Statements - continued
for the year ended 31st March 2024

7. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 4,979 -

Deferred
tax
£   
re: accelerated capital 4,979
allowances
Balance at 31st March 2024 4,979

8. RESERVES
Retained
earnings
£   

At 1st April 2023 51,733
Profit for the year 41,633
Dividends (50,500 )
At 31st March 2024 42,866

9. ULTIMATE CONTROLLING PARTY

The company is under the control of Dr and Mrs Foran .